Continuous
virus production​
for gene therapies
ABOUT OUR PROJECT
ContiVir is a research project of the Max Planck Institute with the vision of operating a unified platform technology for virus production & purification that can produce viral vectors to gene therapy standards at tenfold efficiency compared to today
OUR
TECHNOLOGIES
We are developing a highly efficient virus production system based on a continuous tubular bioreactor & a capture chromatography step with virtually full recovery for a wide range of viruses.
​
These technologies together can be up to ten-fold more efficient than current production platforms.
TUBULAR BIOREACTOR
​
CAPTURE CHROMATOGRAPHY
Video of ContiVir technology:
ADVANTAGES
COMPARED TO BATCH VIRUS PRODUCTION
Reduced footprint
(20 times smaller equipments)
Faster production
(save weeks or months)
Higher productivity
(reduced manufacturing costs)
Applications
Our team
Pavel Marichal, M.Sc.
Co-founder
Downstream processing specialist
Contact us
Sandtorstrasse 1
39106 Magdeburg
Germany
i
​
